These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 208747)

  • 21. Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virus-specific immunoglobulin M, A and G in patients with varicella or herpes zoster.
    van Loon AM; van der Logt JT; Heessen FW; Heeren MC; Zoll J
    Epidemiol Infect; 1992 Feb; 108(1):165-74. PubMed ID: 1312479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of HLA on the cellular immune response to varicella-zoster virus.
    Chiba Y; Miura J; Nakao T; Wakisaka A; Kunikane K
    Biken J; 1985 Jun; 28(1-2):1-7. PubMed ID: 3000347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
    Bergen RE; Sharp M; Sanchez A; Judd AK; Arvin AM
    Viral Immunol; 1991; 4(3):151-66. PubMed ID: 1725699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
    Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
    J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients.
    Ljungman P; Lönnqvist B; Gahrton G; Ringdén O; Sundqvist VA; Wahren B
    J Infect Dis; 1986 May; 153(5):840-7. PubMed ID: 3009635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects.
    Giller RH; Winistorfer S; Grose C
    J Infect Dis; 1989 Dec; 160(6):919-28. PubMed ID: 2555419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular immunity to varicella-zoster virus in patients with major depression.
    Irwin M; Costlow C; Williams H; Artin KH; Chan CY; Stinson DL; Levin MJ; Hayward AR; Oxman MN
    J Infect Dis; 1998 Nov; 178 Suppl 1():S104-8. PubMed ID: 9852986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.
    Prelog M; Schönlaub J; Jeller V; Almanzar G; Höfner K; Gruber S; Eiwegger T; Würzner R
    Vaccine; 2013 May; 31(20):2420-6. PubMed ID: 23583889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella-zoster virus IE63, a virion component expressed during latency and acute infection, elicits humoral and cellular immunity.
    Sadzot-Delvaux C; Arvin AM; Rentier B
    J Infect Dis; 1998 Nov; 178 Suppl 1():S43-7. PubMed ID: 9852972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune evasion as a pathogenic mechanism of varicella zoster virus.
    Abendroth A; Arvin AM
    Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
    Palumbo PE; Arvin AM; Koropchak CM; Wittek AE
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2141-7. PubMed ID: 6096492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic evidence of reinfection with varicella-zoster virus.
    Arvin AM; Koropchak CM; Wittek AE
    J Infect Dis; 1983 Aug; 148(2):200-5. PubMed ID: 6310001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-mediated immunity to varicella-zoster virus: in vitro lymphocyte responses.
    Jordan GW; Merigan TC
    J Infect Dis; 1974 Nov; 130(5):495-501. PubMed ID: 4370611
    [No Abstract]   [Full Text] [Related]  

  • 34. Varicella-zoster virus infection in the pediatric population with acute lymphoblastic leukemia in Poland.
    Zawitkowska J; Lejman M; Szmydki-Baran A; Zaucha-Prażmo A; Czyżewski K; Dziedzic M; Zalas-Więcek P; Gryniewicz-Kwiatkowska O; Czajńska-Deptuła A; Gietka A; Semczuk K; Hutnik Ł; Chełmecka-Wiktorczyk L; Żak I; Frączkiewicz J; Salamonowicz M; Tomaszewska R; Zając-Spychała O; Irga-Jaworska N; Bień E; Płonowski M; Bartnik M; Ociepa T; Pierlejewski F; Machnik K; Gamrot-Pyka Z; Badowska W; Brzeski T; Urbanek-Dądela A; Stolpa W; Mizia-Malarz A; Skowron-Kandzia K; Musiał J; Styczyński J
    J Med Virol; 2020 Dec; 92(12):3645-3649. PubMed ID: 32406935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives on vaccines against varicella-zoster virus infections.
    Gershon AA; Gershon MD
    Curr Top Microbiol Immunol; 2010; 342():359-72. PubMed ID: 20232192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection.
    Arvin AM; Koropchak CM; Williams BR; Grumet FC; Foung SK
    J Infect Dis; 1986 Sep; 154(3):422-9. PubMed ID: 3016110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination.
    Harper DR; Grose C
    J Infect Dis; 1989 Mar; 159(3):444-51. PubMed ID: 2536788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
    Berger R; Luescher D; Just M
    Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences.
    Bender Ignacio RA; Ramchandani MS; Laing KJ; Johnston CM; Koelle DM
    Viral Immunol; 2017; 30(1):77-80. PubMed ID: 27870601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte transformation and interferon production as measures of cellular immunity in lymphoma patients.
    Arvin AM; Pollard RB; Rasmussen LE; Rand KH; Merigan TC
    IARC Sci Publ (1971); 1978; (24 Pt 2):745-51. PubMed ID: 221398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.